
ruptured and intact abdominal aortic aneurysms. J Vasc
Surg 2014;59:315-20.
230. Courtois A, Nusgens BV, Hustinx R, Namur G, Gomez P,
Somja J, et al. 18F-FDG uptake assessed by PET/CT in
abdominal aortic aneurysms is associated with cellular and
molecular alterations prefacing wall deterioration and
rupture. J Nucl Med 2013;54:1740-7.
231. Barwick TD, Lyons OT, Mikhaeel NG, Waltham M,
Oâ€™Doherty MJ. 18F-FDG PET-CT uptake is a feature of both
normal diameter and aneurysmal aortic wall and is not
related to aneurysm size. Eur J Nucl Med Mol Imaging
2014;41:2310-8.
232. Shi S, Orbay H, Yang Y, Graves SA, Nayak TR, Hong H, et al.
PET imaging of abdominal aortic aneurysm with 64Culabeled anti-CD105 antibody Fab fragment. J Nucl Med
2015;56:927-32.
233. Thompson AR, Cooper JA, Ashton HA, Hafez H. Growth
rates of small abdominal aortic aneurysms correlate with
clinical events. Br J Surg 2010;97:37-44.
234. Tedesco MM, Terashima M, Blankenberg FG, Levashova Z,
Spin JM, Backer MV, et al. Analysis of in situ and ex vivo
vascular endothelial growth factor receptor expression
during experimental aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2009;29:1452-7.
235. Kitagawa T, Kosuge H, Chang E, James ML, Yamamoto T,
Shen B, et al. Integrin-targeted molecular imaging of
experimental abdominal aortic aneurysms by 18F-labeled
Arg-Gly-Asp positron-emission tomography. Circ Cardiovas